P.16.3 DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles

Facioscapulohumeral muscular dystrophy (FSHD) is one of the most prevalent adult muscular dystrophies. The common clinical signs usually appear during the second decade of life but when the first molecular dysregulations occur is still unknown. Our aim was to determine whether molecular dysregulations can be identified during FSHD fetal muscle development. We compared muscle biopsies derived from FSHD1 fetuses and the cells derived from some of these biopsies with biopsies and cells derived from control fetuses. We mainly focus on DUX4 isoform expression because the expression of DUX4 has been confirmed in both FSHD cells and biopsies by several laboratories. We measured DUX4 isoform expression by using qRT-PCR in fetal FSHD1 myotubes treated or not with an shRNA directed against DUX4 mRNA. We also analyzed DUX4 downstream target gene expression in myotubes and fetal or adult FSHD1 and control quadriceps biopsies. We show that both DUX4-FL isoforms are already expressed in FSHD1 myotubes. Interestingly, DUX4-FL expression level is much lower in trapezius than in quadriceps myotubes, which is confirmed by the level of expression of DUX4 downstream genes. We observed that TRIM43 and MBD3L2 are already overexpressed in FSHD1 fetal quadriceps biopsies, at similar levels to those observed in adult FSHD1 quadriceps biopsies. These results indicate that molecular markers of the disease are already expressed during fetal life, thus opening a new field of investigation for mechanisms leading to FSHD.

[1]  Daniel G. Miller,et al.  Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells. , 2013, Human molecular genetics.

[2]  F. Magdinier,et al.  Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy. , 2013, Human molecular genetics.

[3]  L. Kunkel,et al.  Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy. , 2013, Human molecular genetics.

[4]  Yi-Wen Chen,et al.  DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? , 2012, Journal of cellular and molecular medicine.

[5]  Daniel G. Miller,et al.  Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2 , 2012, Nature Genetics.

[6]  O. King,et al.  Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. , 2012, Human molecular genetics.

[7]  F. Dilworth,et al.  Turning on Myogenin in Muscle: A Paradigm for Understanding Mechanisms of Tissue-Specific Gene Expression , 2012, Comparative and functional genomics.

[8]  Abraham P. Fong,et al.  DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. , 2012, Developmental cell.

[9]  L. Santoro,et al.  Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling , 2012, Journal of Medical Genetics.

[10]  S. Wilton,et al.  The FSHD Atrophic Myotube Phenotype Is Caused by DUX4 Expression , 2011, PloS one.

[11]  M. Lacey,et al.  Gene expression during normal and FSHD myogenesis , 2011, BMC Medical Genomics.

[12]  S. Tapscott,et al.  Immunodetection of human double homeobox 4. , 2011, Hybridoma.

[13]  Rabi Tawil,et al.  Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. , 2011, Trends in molecular medicine.

[14]  S. Harper,et al.  DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53‐dependent myopathy in vivo , 2011, Annals of neurology.

[15]  M. Tarnopolsky,et al.  Clinical features of facioscapulohumeral muscular dystrophy 2 , 2010, Neurology.

[16]  Daniel G. Miller,et al.  Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene , 2010, PLoS genetics.

[17]  Daniel G. Miller,et al.  A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy , 2010, Science.

[18]  R. Wuebbles,et al.  Testing the effects of FSHD candidate gene expression in vertebrate muscle development. , 2010, International journal of clinical and experimental pathology.

[19]  M. Kimmel,et al.  Conflict of interest statement. None declared. , 2010 .

[20]  Daniel G. Miller,et al.  RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. , 2009, Human molecular genetics.

[21]  M. Kyba,et al.  An isogenetic myoblast expression screen identifies DUX4‐mediated FSHD‐associated molecular pathologies , 2008, The EMBO journal.

[22]  H. Qian,et al.  DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1 , 2007, Proceedings of the National Academy of Sciences.

[23]  A. Rosa,et al.  The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein , 2007, Neuromuscular Disorders.

[24]  N. Thomas,et al.  A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere , 2006, Journal of Medical Genetics.

[25]  R. Tawil,et al.  Facioscapulohumeral muscular dystrophy , 2006, Muscle & nerve.

[26]  R. Frants,et al.  The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy. , 2005, American journal of human genetics.

[27]  R. Frants,et al.  Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy. , 2004, American journal of human genetics.

[28]  L. Sandkuijl,et al.  Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy. , 2004, American journal of human genetics.

[29]  G. V. Ommen,et al.  Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere , 2002, Nature Genetics.

[30]  Markus R Wenk,et al.  Amphiphysin 2 (Bin1) and T-Tubule Biogenesis in Muscle , 2002, Science.

[31]  H. Ding,et al.  Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. , 1999, Gene.

[32]  R. Tupler,et al.  Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. , 1996, Journal of medical genetics.

[33]  J E Hewitt,et al.  FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. , 1993, Human molecular genetics.

[34]  P Halonen,et al.  [Facioscapulohumeral muscular dystrophy]. , 1990, Duodecim; laaketieteellinen aikakauskirja.